Table 1 Distribution (proportion or mean and 95% confidence intervals) of lifestyle risk factors associated with cancer incidence and mortality in Chile
From: Cancer cases and deaths attributable to lifestyle risk factors in Chile
Exposure and distribution and theoretical minimum risk exposure level (in italic) | Men | Women | Cancer sites-related (ICD-10) |
|---|---|---|---|
Alcohol consumption (%) | |||
Abstainer (0 g/day) | 20.5 (18.7–22.5) | 44.1 (42.2–45.7) | Lip, oral cavity, pharynx (C00-C14); Esophagus (C15; squamous cell carcinoma only); Colorectum (C18-C20); Liver (C22); Gallbladder (C23); Pancreas (C25); Larynx (C32); female Breast (C50) |
 Light (1–12.5 g/day) | 31.5 (29.3–33.6) | 41.4 (39.8–43.2) | |
 Moderate (12.6–49.9 g/day) | 39.1 (37.0–41.5) | 13.8 (12.6–14.8) | |
 Heavy (≥50 g/day) | 8.8 (7.6–10.2) | 0.7 (0.4–1.0) | |
High body mass index (in kg/m2) | |||
 Mean and standard deviation (22 kg/m2and 1 sd) | 28.42 (28.20–28.65) | 29.62 (29.43–29.83) | Esophagus (C15; adenocarcinoma only); Stomach (C16.0; cardia only); Colorectum (C18-C20); Liver (C22); Gallbladder (C23); Pancreas (C25); female Breast (C50; postmenopausal cancers only); Corpus uteri (C54-C55); Ovary (C56); Kidney, renal pelvis (C64-C66); Thyroid (C73); Multiple myeloma (C90). Prostate (C61; advanced only) |
Low fruits and vegetables consumption (%) | |||
≥400 g/day | 11.6 (10.3–12.9) | 14.7 (13.6–15.9) | Oral cavity/pharynx (C00-C14); Larynx (C32) |
 300–399 g/day | 9.1 (7.9–10.4) | 11.9 (10.9–13.0) | |
 200–299 g/day | 18.1 (16.4–19.8) | 19.8 (18.5–21.1) | |
 100–199 g/day | 38.0 (35.9–40.2) | 36.9 (35.4–38.4) | |
 0–99 g/day | 23.2 (21.5–25.9) | 16.6 (15.4–17.8) | |
Low fruits consumption only (%) | |||
≥250 g/day | 6.2 (5.2–7.2) | 6.5 (5.7–7.3) | Lung, bronchus. Trachea (C33-C34) |
 200–249 g/day | 6.1 (5.1–7.2) | 7.9 (7.1–8.8) | |
 150–199 g/day | 11.2 (9.9–12.7) | 15.4 (14.3–16.5) | |
 100–149 g/day | 7.7 (6.5–8.9) | 6.1 (5.4–6.9) | |
 50–99 g/day | 27.5 (25.6–29.4) | 30.5 (29.0–32.0) | |
 0–49 g/day | 41.2 (39.1–43.5) | 33.6 (32.1–35.1) | |
Lack of physical activity (%) | |||
≥8000 MET-min/week | 0.6 (0.3–0.9) | 0.2 (0.1–0.4) | Colon (C18); female Breast (C50; post-menopausal cancers only) |
 4000–7999 MET-min/week | 5.1 (4.1–6.1) | 1.8 (1.4–2.2) | |
 600–3999 MET-min/week | 23.6 (21.9–25.4) | 13.7 (12.6–14.8) | |
 <  600 MET-min/week | 70.7 (68.8–72.7) | 84.3 (83.1–85.5) | |
Passive smoking (%) | |||
No | 82.7 (81.0–84.3) | 87.0 (85.9–88.1) | Lung, bronchus, trachea (C33-C34) |
 yes | 17.3 (15.7–19.0) | 13.0 (11.9–14.1) | |
Smoking (%) | |||
Never | 37.7 (35.6–39.8) | 52.6 (51.0–54.1) | Oral cavity/pharynx (C00-C14); Esophagus (C15); Stomach (C16); Colorectum (C18-C20); Liver (C22); Pancreas (C25); Nasal cavity/paranasal sinus (C30-C31); Larynx (C32); Lung, bronchus, trachea (C33-C34); Cervix (C53); Kidney, renal pelvis, ureter(C64-C66); Urinary bladder (C67); Myeloid leukemia (C92) |
 Former | 28.9 (27.0–30.9) | 21.6 (20.4–22.9) | |
 Current | 33.4 (31–3-35.4) | 25.8 (24.4–27.1) | |